Aridis pharmaceuticals announces first quarter 2023 financial results and business update

Los gatos, calif., june 08, 2023 (globe newswire) -- aridis pharmaceuticals, inc. (nasdaq: ards), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies for treating life-threatening infections, today reported financial and corporate results for its first quarter ended march 31, 2023.
ARDS Ratings Summary
ARDS Quant Ranking